Gut-dependent microbial translocation induces inflammation and cardiovascular events after ST-elevation myocardial infarction

Abstract

Our results provide the first evidence that cardiovascular outcomes post-MI are driven by intestinal microbiota translocation into systemic circulation. New therapeutic strategies targeting to protect the gut barrier and eliminate gut bacteria translocation may reduce or even prevent cardiovascular events post-MI.